IO Biotech, Inc.

NASDAQ:IOBT

1.5 (USD) • At close June 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -95.491-86.083-71.458-67.879-12.042-10.743
Depreciation & Amortization 0.8490.7560.540.00200
Deferred Income Tax 000.087-0.00200
Stock Based Compensation 6.5268.0597.041.7910.0640.131
Change In Working Capital 2.185.8624.192-0.7760.1480.893
Accounts Receivables 000000
Inventory 000000
Accounts Payables 0.782-0.1260.0773.406-0.4750.103
Other Working Capital 1.3985.9884.115-4.1820.6230.79
Other Non Cash Items 3.589-0.331-0.1326.2161.8740.828
Operating Cash Flow -82.347-71.737-59.729-40.646-9.956-8.891
Investing Activities:
Investments In Property Plant And Equipment -0.044-0.323-0.69-0.15300
Acquisitions Net 000000
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites 000000
Investing Cash Flow -0.044-0.323-0.69-0.15300
Financing Activities:
Debt Repayment 000000
Common Stock Issued 075.0580115.1155.1020
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 0-6.3960137.8365.1029.014
Financing Cash Flow 071.860252.9515.1029.014
Other Information:
Effect Of Forex Changes On Cash -0.7710.803-8.522-3.7580.413-0.248
Net Change In Cash -83.1620.603-68.941208.394-4.441-0.125
Cash At End Of Period 60.299143.461142.858211.7993.4057.846